AU Patent

AU2014221210C1 — The use of solid carrier particles to improve the processability of a pharmaceutical agent

Assigned to Gilead Sciences Inc · Expires 2017-06-01 · 9y expired

What this patent protects

The invention provides a composition comprising, a compound of formula (I) or a pharmaceutically acceptable salt thereof and a plurality of solid carrier particles, as well as methods for using the composition to inhibit the activity of cytochrome P-450.

USPTO Abstract

The invention provides a composition comprising, a compound of formula (I) or a pharmaceutically acceptable salt thereof and a plurality of solid carrier particles, as well as methods for using the composition to inhibit the activity of cytochrome P-450.

Drugs covered by this patent

Patent Metadata

Patent number
AU2014221210C1
Jurisdiction
AU
Classification
—
Expires
2017-06-01
Drug substance claim
No
Drug product claim
No
Assignee
Gilead Sciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.